Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk (2019) Pachera E, Assass S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution Hsp90 as a Potential Biomarker of Lung and Skin Involvement in Patients with Systemic Sclerosis (2019) Storkanova H, Oreska S, Spiritovic M, Hermankova B, Bubova K, Komarc M, Pavelka K, et al. Conference contribution Individually Tailored Predictions of Flare Probability for Rheumatoid Arthritis Patients on Biologic DMARDs Based on Machine Learning Stacking Meta-Classifier (2019) Vodencarevic A, Simon D, Hartmann F, Reiser M, Hueber A, Tascilar K, Kleyer A, et al. Conference contribution Psoriatic Arthritis - Epidemiology, Incidence Rate in Psoriasis Patients, Comorbidity Profiles and Risk Factor Analysis (2019) Rech J, Sticherling M, Biermann M, Haeberle B, Reinhardt M Conference contribution The Urge for Mobile Apps in Rheumatology - a German Patient Perspective (2019) Knitza J, Raab C, Lambrecht A, Simon D, Hagen M, Bayat S, Schett G, et al. Conference contribution The Effect of Nintedanib versus Mycopheolate Mofetil in the FRA2 Mouse Model of Systemic Sclerosis Associated Interstitial Lung Disease (2019) Thuong Trin-Minh , Zhang Y, Distler J, Wollin L Conference contribution Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission (2019) Hagen M, Tascilar K, Reiser M, Haschka J, Kleyer A, Valor L, Manger B, et al. Conference contribution Adipocytokines and Obesity in the Context of Rheumatoid and Osteoarthritis Mouse Models (2019) Sauermilch HM, Huelser ML, Schreiyaeck C, Luo Y, Bozec A, Schett G, Mueller-Ladner U, Neumann E Conference contribution The Relationship Between Subclinical Inflammation and Bone Damage in Patients with Rheumatoid Arthritis Using Multimodality Imaging (2019) Brunet S, Salat P, Hazlewood G, Engelke K, Barnabe C, Manske S Conference contribution Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airo P, Vettori S, Cozzi F, et al. Journal article